1. Åhlin, A., Gyllenhammar, H., Ringertz, B. and Palmblad,J. (1995). Neutrophil membrane potential changes and homotyic aggregation kinetics are pH-dependent: studies of chronic granulomatous disease. J. Lab. Clin. Med.125,392-401.
2. Babior, B. M. (1999). NADPH oxidase: an update. Blood93,1464-1476.
3. Bánfi, B., Schrenzel, J., Nüsse, O., Lew, D. P.,Ligeti, E., Krause, K.-H. and Demaurex, N. (1999). A novel H+conductance in eosinophils: unique characteristics and absence in chronic granulomatous disease. J. Exp. Med.190,183-194.
4. Bankers-Fulbright, J. L., Kephart, G. M., Loegering, D. A.,Bradford, A. L., Okada, S., Kita, H. and Gleich, G. J.(1998). Sulfonylureas inhibit cytokine-induced eosinophil survival and activation. J. Immunol.160,5546-5553.
5. Bankers-Fulbright, J. L., Kita, H., Gleich, G. J. and O'Grady,S. M. (2001). Regulation of human eosinophil NADPH oxidase activity: a central role for PKCδ. J. Cell. Physiol.189,306-315.